.Terns Pharmaceuticals' choice to drop its liver condition ambitions may yet settle, after the biote...
.Merck & Co.'s long-running attempt to land a blow on small cell lung cancer (SCLC) has racked up...
.Some people with non-small cell bronchi cancer (NSCLC) have mutations in a genetics referred to as ...
.MBX has fleshed out strategies to take in over $136 million from its own IPO as the biotech seeks t...
.Relay Rehabs has hammered its survival target in a first-in-human boob cancer research study, posit...
.AstraZeneca has made use of artificial intelligence to devise a special biomarker for its own Daiic...
.AstraZeneca executives mention they are "not troubled" that the failing of tozorakimab in a phase 2...
.Welcome to today's Chutes & Ladders, our summary of considerable management hirings, firings and...
.After revealing strategies to hit the U.S. social markets less than a month earlier, Zenas Biopharm...
.Psyence Biomedical is paying $500,000 in portions to obtain fellow psilocybin-based biotech Clairvo...